Skip to main content
Premium Trial:

Request an Annual Quote

Tough Times for GWAS

Here's a post from the Annals of Neurology blog reacting to the problems that arose as scientists realized they could identify individuals even from seemingly "anonymized" pooled DNA samples. This threatens to halt advances from genome-wide associations studies, writes Brenda Patoine, "just as the power of these studies to detect risk-conferring alleles in complex genetic diseases is being realized." She notes that the NIH decision to close access to its GWAS databases has had "ripple effects throughout the genetics research community, as universities mull whether to pull data from their own Web sites and grapple with issues of informed consent in the face of the apparent vulnerabilities to participant confidentiality."

 

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.